Đang chuẩn bị liên kết để tải về tài liệu:
Febrile neutropenia (FN) occurrence outside of clinical trials: Occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinational study

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Febrile neutropenia (FN) is a common occurrence during chemotherapy. Granulocyte colony-stimulating factors (G-CSFs) can significantly reduce the risk of FN. International guidelines recommend G-CSF for patients receiving chemotherapy with FN risk of ≥20% or 10% to 20% with defined risk factors. | Febrile neutropenia FN occurrence outside of clinical trials Occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective observational multinational study

TÀI LIỆU LIÊN QUAN

Febrile neutropenia (FN) occurrence outside of clinical trials: Occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinational study

Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia

Biosimilar filgrastim treatment patterns and prevention of febrile neutropenia: A prospective multicentre study in France in patients with solid tumours (the ZOHé study)

Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors

Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: A systematic review and meta-analysis

A clinical study of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in preventing neutropenia during concurrent chemoradiotherapy of cervical cancer

Fluoroquinolone resistance in bacteremic and low risk febrile neutropenic patients with cancer

Study design: Two long-term observational studies of the biosimilar filgrastim Nivestim™ (Hospira filgrastim) in the treatment and prevention of chemotherapy-induced neutropenia

báo cáo khoa học: "Persistent Tn polyagglutination syndrome during febrile neutropenia: a case report and review of the literature Loaiza-Bonilla et al."

Usefulness of positron emission tomography in the differentiation between tumor and infectious lesions in pediatric oncology: A case report
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.